Industry leaders are leveraging AI and data analytics to transform biologics development and drug discovery. Sanofi's iCMC digital transformation program employs data, machine learning, and automation to create predictive bioprocessing models, accelerating development and increasing efficiency. VantAI and Halda Therapeutics entered a $1 billion+ collaboration combining AI-driven protein interaction prediction with proximity-based cancer therapies. Additionally, advances in AI improve mammogram interpretation accuracy by assisting radiologists and novel AI methods increase reliability in medical diagnostics, highlighting the expanding role of artificial intelligence in biotech.